Which aspects of HTS are empirically correlated with downstream success?
- PMID: 18428086
Which aspects of HTS are empirically correlated with downstream success?
Abstract
High-throughput screening (HTS) is a well-established hit-finding approach used in the pharmaceutical industry. In this article, recent experience at Novartis with respect to factors influencing the success of HTS campaigns is discussed. An inherent measure of HTS quality could be defined by the assay Z and Z' factors, the number of hits and their biological potencies; however, such measures of quality do not always correlate with the advancement of hits to the later stages of drug discovery. Also, for many target classes, such as kinases, it is easy to identify hits, but, as a result of selectivity, intellectual property and other issues, the projects do not result in lead declarations. In this article, HTS success is defined as the fraction of HTS campaigns that advance into the later stages of drug discovery, and the major influencing factors are examined. Interestingly, screening compounds in individual wells or in mixtures did not have a major impact on the HTS success and, equally interesting, there was no difference in the progression rates of biochemical and cell-based assays. Particular target types, assay technologies, structure-activity relationships and powder availability had a much greater impact on success as defined above. In addition, significant mutual dependencies can be observed - while one assay format works well with one target type, this situation might be completely reversed for a combination of the same readout technology with a different target type. The results and opinions presented here should be regarded as groundwork, and a plethora of factors that influence the fate of a project, such as biophysical measurements, chemical attractiveness of the hits, strategic reasons and safety pharmacology, are not covered here. Nonetheless, it is hoped that this information will be used industry-wide to improve success rates in terms of hits progressing into exploratory chemistry and beyond. The support that can be obtained from new in silico approaches to phase transitions are also described, along with the gaps they are designed to fill.
Similar articles
-
Novel trends in high-throughput screening.Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21. Curr Opin Pharmacol. 2009. PMID: 19775937 Review.
-
Affinity-based screening techniques for enhancing lead discovery.Curr Opin Drug Discov Devel. 2004 Jul;7(4):411-6. Curr Opin Drug Discov Devel. 2004. PMID: 15338950 Review.
-
Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.Curr Opin Drug Discov Devel. 2003 May;6(3):370-6. Curr Opin Drug Discov Devel. 2003. PMID: 12833670 Review.
-
The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".Curr Opin Drug Discov Devel. 2008 Jul;11(4):553-8. Curr Opin Drug Discov Devel. 2008. PMID: 18600571 Review.
-
Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.Expert Opin Drug Discov. 2010 Nov;5(11):1095-107. doi: 10.1517/17460441.2010.524641. Epub 2010 Oct 7. Expert Opin Drug Discov. 2010. PMID: 22827747 Review.
Cited by
-
Human Serum Alters the Metabolism and Antibiotic Susceptibility of Staphylococcus aureus.J Proteome Res. 2022 Jun 3;21(6):1467-1474. doi: 10.1021/acs.jproteome.2c00073. Epub 2022 May 10. J Proteome Res. 2022. PMID: 35537087 Free PMC article.
-
Are phylogenetic trees suitable for chemogenomics analyses of bioactivity data sets: the importance of shared active compounds and choosing a suitable data embedding method, as exemplified on Kinases.J Cheminform. 2013 Dec 13;5(1):49. doi: 10.1186/1758-2946-5-49. J Cheminform. 2013. PMID: 24330772 Free PMC article.
-
Plate-based diversity subset screening: an efficient paradigm for high throughput screening of a large screening file.Mol Divers. 2013 May;17(2):319-35. doi: 10.1007/s11030-013-9438-x. Epub 2013 Apr 5. Mol Divers. 2013. PMID: 23559278
-
A prospective compound screening contest identified broader inhibitors for Sirtuin 1.Sci Rep. 2019 Dec 20;9(1):19585. doi: 10.1038/s41598-019-55069-y. Sci Rep. 2019. PMID: 31863054 Free PMC article.
-
Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression.Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3585-90. doi: 10.1073/pnas.0813345106. Epub 2009 Feb 10. Proc Natl Acad Sci U S A. 2009. PMID: 19208811 Free PMC article.